LifeStance Health Group (LFST) Set to Release Quarterly Earnings on Thursday

LifeStance Health Group (NASDAQ:LFST) will likely be posting its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect LifeStance Health Group to announce earnings of $0.0369 per share and revenue of $431.59 million for the quarter. Individuals may visit the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:30 AM ET.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.03. The firm had revenue of $435.35 million for the quarter, compared to analyst estimates of $414.58 million. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%. The company’s revenue was up 26.1% on a year-over-year basis. During the same quarter last year, the company earned ($0.01) EPS. On average, analysts expect LifeStance Health Group to post $0.16 EPS for the current fiscal year and $0.23 EPS for the next fiscal year.

LifeStance Health Group Price Performance

Shares of NASDAQ LFST opened at $13.26 on Tuesday. The business has a fifty day moving average price of $12.50 and a two-hundred day moving average price of $9.37. The stock has a market capitalization of $5.07 billion, a PE ratio of 102.01 and a beta of 1.24. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. LifeStance Health Group has a fifty-two week low of $4.77 and a fifty-two week high of $13.76.

Insider Transactions at LifeStance Health Group

In related news, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of LifeStance Health Group stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $10.62, for a total value of $144,890,858.34. Following the transaction, the insider directly owned 98,101,407 shares of the company’s stock, valued at $1,041,836,942.34. The trade was a 12.21% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Lisa Miller sold 47,912 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $10.85, for a total value of $519,845.20. Following the completion of the sale, the chief operating officer owned 281,289 shares in the company, valued at $3,051,985.65. The trade was a 14.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 13,777,580 shares of company stock worth $146,433,781 over the last ninety days. 3.50% of the stock is owned by insiders.

Wall Street Analyst Weigh In

LFST has been the subject of a number of analyst reports. Zacks Research downgraded LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 13th. BTIG Research raised their target price on shares of LifeStance Health Group from $16.00 to $18.00 and gave the company a “buy” rating in a report on Wednesday, August 19th. Wall Street Zen downgraded shares of LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 5th. Weiss Ratings upgraded shares of LifeStance Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 11th. Finally, KeyCorp boosted their price target on LifeStance Health Group from $13.00 to $15.00 and gave the stock an “overweight” rating in a report on Monday, October 5th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $13.12.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc is a provider of outpatient behavioral health services in the United States. Through a network of clinicians and care centers, the company offers mental health care through in-person appointments and telehealth visits.

LifeStance’s services include individual, couples and family therapy; psychiatric evaluation and medication management; psychological and neuropsychological testing; and treatment for conditions such as depression, anxiety, attention-deficit/hyperactivity disorder, bipolar disorder, post-traumatic stress disorder and other behavioral health concerns.